The Emerging Role of Carbon-Ion Radiotherapy

Carbon-ion radiotherapy (CIRT) has progressed rapidly in technological delivery, indications, and efficacy. Owing to a focused dose distribution in addition to high linear energy transfer and subsequently high relative biological effect, CIRT is uniquely able to target otherwise untreatable hypoxic...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebner, Daniel K., Kamada, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894867/
https://www.ncbi.nlm.nih.gov/pubmed/27376030
http://dx.doi.org/10.3389/fonc.2016.00140
_version_ 1782435732334313472
author Ebner, Daniel K.
Kamada, Tadashi
author_facet Ebner, Daniel K.
Kamada, Tadashi
author_sort Ebner, Daniel K.
collection PubMed
description Carbon-ion radiotherapy (CIRT) has progressed rapidly in technological delivery, indications, and efficacy. Owing to a focused dose distribution in addition to high linear energy transfer and subsequently high relative biological effect, CIRT is uniquely able to target otherwise untreatable hypoxic and radioresistant disease while opening the door for substantially hypofractionated treatment of normal and radiosensitive disease. CIRT has increasingly garnered international attention and is nearing the tipping point for international adoption.
format Online
Article
Text
id pubmed-4894867
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-48948672016-07-01 The Emerging Role of Carbon-Ion Radiotherapy Ebner, Daniel K. Kamada, Tadashi Front Oncol Oncology Carbon-ion radiotherapy (CIRT) has progressed rapidly in technological delivery, indications, and efficacy. Owing to a focused dose distribution in addition to high linear energy transfer and subsequently high relative biological effect, CIRT is uniquely able to target otherwise untreatable hypoxic and radioresistant disease while opening the door for substantially hypofractionated treatment of normal and radiosensitive disease. CIRT has increasingly garnered international attention and is nearing the tipping point for international adoption. Frontiers Media S.A. 2016-06-07 /pmc/articles/PMC4894867/ /pubmed/27376030 http://dx.doi.org/10.3389/fonc.2016.00140 Text en Copyright © 2016 Ebner and Kamada. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Ebner, Daniel K.
Kamada, Tadashi
The Emerging Role of Carbon-Ion Radiotherapy
title The Emerging Role of Carbon-Ion Radiotherapy
title_full The Emerging Role of Carbon-Ion Radiotherapy
title_fullStr The Emerging Role of Carbon-Ion Radiotherapy
title_full_unstemmed The Emerging Role of Carbon-Ion Radiotherapy
title_short The Emerging Role of Carbon-Ion Radiotherapy
title_sort emerging role of carbon-ion radiotherapy
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894867/
https://www.ncbi.nlm.nih.gov/pubmed/27376030
http://dx.doi.org/10.3389/fonc.2016.00140
work_keys_str_mv AT ebnerdanielk theemergingroleofcarbonionradiotherapy
AT kamadatadashi theemergingroleofcarbonionradiotherapy
AT ebnerdanielk emergingroleofcarbonionradiotherapy
AT kamadatadashi emergingroleofcarbonionradiotherapy

Ejemplares similares